SLC5A2 and acute kidney injury: The analysis revealed no significant differences between the two groups in terms of mortality, hospital discharge, the need for mechanical ventilation, renal replacement therapy, acute kidney injury, or ketoacidosis associated with SGLT2 inhibitor use.